Turn Therapeutics Inc. (TTRX)
Nasdaq: TTRX · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2024
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 31, 2026 | · |
| Research and development | 265,570 | 245,956 |
| General and administrative | 5,593,078 | 1,551,168 |
| Total operating expenses | 5,858,648 | 1,797,124 |
| Operating income | -5,858,648 | -1,797,124 |
| Interest and investment income | 29,583 | 28,709 |
| Other income (expense), net | 176,520 | · |
| Total non-operating income (expense) | 2,664,568 | 28,709 |
| Net income | -3,194,080 | -1,768,415 |
| Earnings per share, basic | -0.12 | -0.07 |
| Earnings per share, diluted | -0.12 | -0.07 |
| Weighted average shares, basic | 27,716,045 | 26,643,432 |
| Weighted average shares, diluted | 27,716,045 | 26,643,432 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding